Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.57 - $35.08 $906,279 - $3.32 Million
94,700 Added 498.42%
113,700 $3.35 Million
Q2 2024

Aug 14, 2024

SELL
$12.35 - $26.11 $56,810 - $120,106
-4,600 Reduced 19.49%
19,000 $234,000
Q1 2024

May 15, 2024

BUY
$18.44 - $26.41 $435,184 - $623,276
23,600 New
23,600 $478,000
Q3 2023

Nov 15, 2023

BUY
$16.64 - $25.32 $406,016 - $617,808
24,400 Added 60.7%
64,600 $1.07 Million
Q2 2023

Aug 23, 2023

SELL
$21.59 - $27.88 $207,264 - $267,648
-9,600 Reduced 19.28%
40,200 $985,000
Q1 2023

May 15, 2023

SELL
$23.46 - $36.44 $1.06 Million - $1.65 Million
-45,300 Reduced 47.63%
49,800 $1.2 Million
Q4 2022

Feb 14, 2023

BUY
$27.82 - $44.16 $2.65 Million - $4.2 Million
95,100 New
95,100 $2.81 Million
Q2 2022

Aug 15, 2022

SELL
$17.22 - $38.47 $36,162 - $80,787
-2,100 Reduced 2.42%
84,500 $2.51 Million
Q1 2022

May 16, 2022

SELL
$32.6 - $53.05 $648,740 - $1.06 Million
-19,900 Reduced 18.69%
86,600 $3.34 Million
Q4 2021

Feb 14, 2022

SELL
$36.77 - $90.91 $2.33 Million - $5.75 Million
-63,300 Reduced 37.28%
106,500 $4.66 Million
Q3 2021

Nov 12, 2021

BUY
$41.79 - $135.3 $2.64 Million - $8.55 Million
63,200 Added 59.29%
169,800 $10.6 Million
Q2 2021

Aug 06, 2021

BUY
$32.15 - $89.72 $890,555 - $2.49 Million
27,700 Added 35.11%
106,600 $8.85 Million
Q1 2021

May 14, 2021

BUY
$7.09 - $87.95 $559,401 - $6.94 Million
78,900 New
78,900 $3.47 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.06B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.